--- title: "Harvard Bioscience (HBIO.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/HBIO.US/norm.md" symbol: "HBIO.US" name: "Harvard Bioscience" parent: "https://longbridge.com/en/quote/HBIO.US.md" datetime: "2026-03-14T09:12:40.873Z" locales: - [en](https://longbridge.com/en/quote/HBIO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/HBIO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/HBIO.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/HBIO.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/HBIO.US/norm.md) # Harvard Bioscience (HBIO.US) — Financial Reports ## Income Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | -0.0638 | -0.0300 | -0.0515 | -1.14 | 0.0004 | | ROE | -81.92% | -33.05% | -59.72% | -515.15% | 0.11% | | Revenue | 23.73M | 20.59M | 20.45M | 21.77M | 24.56M | | Net income | -2.85M | -1.23M | -2.28M | -50.34M | 18000.00 | | Operating income | 1.71M | 245000.00 | -619000.00 | -1.62M | 459000.00 | | Gross margin | 59.71% | 58.38% | 56.40% | 55.96% | 57.23% | | Net margin | -11.99% | -5.98% | -11.16% | -231.19% | 0.07% | | Profit quality | -1781.25% | 22.60% | -22.47% | -54.39% | 26.61% | ## Balance Sheet (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 80.07M | 77.99M | 80.09M | 79.80M | 126.64M | | Leverage | 5.83 | 5.54 | 5.09 | 5.38 | 2.00 | | BVPS | 0.3079 | 0.3156 | 0.3533 | 0.3355 | 1.44 | | Turnover | - | 0.8352 | 0.8493 | 0.8583 | 0.7131 | | Cash & STI | 8.61M | 6.82M | 7.44M | 5.55M | 4.11M | | Inv & Rec | 20.80M | 21.60M | 22.25M | 22.82M | 23.25M | | LT assets | 4.79M | 12.49M | 12.04M | 12.29M | 11.24M | | Net debt | 27.26M | 35.97M | 35.92M | 39.06M | 40.39M | ## Cash Flow Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | -96000.00 | 1.08M | 2.75M | 2.99M | 1.73M | | Investing CF | -599000.00 | -348000.00 | -233000.00 | -683000.00 | -466000.00 | | Financing CF | 2.45M | -1.28M | -1.26M | -1.20M | -1.36M | | Free CF | 863750.00 | 2.05M | 3.96M | 3.59M | 2.58M | | OCF coverage | -0.28% | 89.81% | 252.98% | 197.36% | 132.59% | | Repaid & issued | 40.00M | - | - | - | 0.0000 | | CapEx | -449000.00 | -207000.00 | -89000.00 | -513000.00 | -301000.00 |